UiPath Stock Screams Undervalued as Market Overlooks Its RPA Dominance

UiPath Inc. PATH is trading at a discount that growth investors shouldn't ignore. With a forward 12-month price-to-sales (P/S) ratio of just 4.18X — well below the industry average of 5.85X — UiPath looks like a rare undervalued gem in the fast-evolving automation landscape. This disparity isn’t a sign of weakness; rather, it reflects a cautious market that may be underestimating the company’s long-term potential. As a dominant force in robotic process automation (RPA), UiPath is scaling across critical industries like finance, healthcare, and logistics, supported by robust recurring revenue and a rapidly expanding global footprint.

While macro headwinds and tech-sector volatility may be fueling short-term hesitation, PATH’s fundamentals tell a different story. Its deeply integrated developer ecosystem, breadth of automation tools, and enterprise-grade capabilities put it at the center of digital transformation initiatives worldwide. Strategic partnerships with heavyweights like Microsoft and SAP further solidify its relevance and ensure its AI-driven automation suite remains indispensable to large-scale operations.

The Undervalued Challenger Among Giants

Compared to established enterprise players, like ServiceNow NOW and Pegasystems PEGA, PATH’s valuation looks strikingly modest. ServiceNow, riding high on profitability and a wide product suite, commands a forward P/S of 13.89X, more than triple UiPath’s. Pegasystems, while similar in automation focus, trades at 4.98X despite slower growth and a narrower automation scope. This suggests UiPath not only offers better growth dynamics but does so at a significantly lower valuation, making it a compelling option for investors seeking enterprise software exposure without the premium price tag.

For those eyeing next-gen automation plays, Pegasystems presents a useful benchmark, but PATH may hold greater upside. Likewise, while ServiceNow continues to dominate the enterprise IT landscape, UiPath’s automation-first strategy offers a differentiated and potentially more scalable growth path.

Performance and Sentiment: Poised for Repricing?

Despite lagging the industry’s 30% rally over the past three months with an 11% gain, PATH hasn’t lost analyst confidence. 

The Zacks Consensus Estimate for second-quarter fiscal 2026 earnings has held steady, and the stock boasts a Zacks Rank #1 (Strong Buy), a testament to confidence in its operational trajectory.

Investors willing to look past temporary sentiment and focus on fundamentals may find UiPath’s discounted valuation, relentless innovation, and strategic position in enterprise automation too good to pass up. The market may be sleeping on UiPath, but forward-thinking investors shouldn’t.

You can see the complete list of today’s Zacks #1 Rank stocks here.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

This article originally published on Zacks Investment Research (zacks.com).

Zacks Investment Research